Mitochondria-based photodynamic anti-cancer therapy

Citation
J. Morgan et Ar. Oseroff, Mitochondria-based photodynamic anti-cancer therapy, ADV DRUG DE, 49(1-2), 2001, pp. 71-86
Citations number
140
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ADVANCED DRUG DELIVERY REVIEWS
ISSN journal
0169409X → ACNP
Volume
49
Issue
1-2
Year of publication
2001
Pages
71 - 86
Database
ISI
SICI code
0169-409X(20010702)49:1-2<71:MPAT>2.0.ZU;2-M
Abstract
As photodynamic therapy (PDT) becomes established as a treatment for cancer , there is increasing interest in identifying critical mechanisms of cell k illing and understanding the bases for effective photosensitizers. The exis tence of multiple cellular targets makes it difficult to distinguish the cr itical events leading to cell death from PDT. However, with more sensitive techniques to detect photosensitizer localization, the isolation of PDT-res istant and -sensitive mutants and the use of innovative molecular and bioch emical strategies to map cellular events occurring during and after photose nsitization, some order is emerging from the chaos. The subcellular localiz ation of many photosensitizers and the early responses to light activation indicate that mitochondria play a major role in photodynamic cell death. PD T with many agents which damage or inhibit different or multiple mitochondr ial targets has many of the desirable characteristics for an effective anti -cancer therapy. (C) 2001 Elsevier Science B.V. All rights reserved.